The blood–brain barrier

Cold Spring Harbor Perspectives in Biology

Volumn 7, Issue 1, 2015, Pages

  Daneman, Richard ^a   Prat, Alexandre ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASTROCYTE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASE; CYTOLOGY; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TIGHT JUNCTION; VASCULAR SMOOTH MUSCLE;

ASTROCYTES; BASEMENT MEMBRANE; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASES; ENDOTHELIAL CELLS; HOMEOSTASIS; HUMANS; MUSCLE, SMOOTH, VASCULAR; TIGHT JUNCTIONS;

EID: 84920528714     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a020412     Document Type: Article

References (156)

1. Abbott NJ, Khan EU, Rollinson CM, Reichel A, Janigro D, Dombrowski SM, Dobbie MS, Begley DJ. 2002. Drug resistance in epilepsy: The role of the blood–brain barrier. Novartis Found Symp 243: 38–47; discussion 47–53, 180–185.
2. Abbott NJ, Ronnback L, Hansson E. 2006. Astrocyte–endo-thelial interactions at the blood–brain barrier. Nat Rev Neurosci 7: 41–53.
3. Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, Sorokin LM. 2006. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med 203: 1007–1019.
4. Aird WC. 2007a. Phenotypic heterogeneity of the endothe-lium: II. Representative vascular beds. Circ Res 100: 174–190.
5. Aird WC. 2007b. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100: 158–173.
6. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM. 2007. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 10: 1538–1543.
7. Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, Terouz S, Sabbagh M, Wosik K, Bourbonnière L, Bernard M, et al. 2011a. The Hedgehog pathway promotes blood–brain barrier integrity and CNS immune quiescence. Science 334: 1727–1731.
8. Alvarez JI, Cayrol R, Prat A. 2011b. Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta 1812: 252–264.
9. Alvarez JI, Katayama T, Prat A. 2013. Glial influence on the blood brain barrier. Glia 61: 1939–1958.
10. Amasheh S, Schmidt T, Mahn M, Florian P, Mankertz J, Tavalali S, Gitter AH, Schulzke JD, Fromm M. 2005. Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells. Cell Tissue Res 321: 89–96.
11. Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR. 2009. VEGF-mediated disruption of endothelial CLN-5 promotes blood–brain barrier breakdown. Proc Natl Acad Sci 106: 1977–1982.
12. Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG, et al. 2012. Astrocyte-derived VEGF-A drives blood–brain barrier disruption in CNS inflammatory disease. J Clin Invest 122: 2454–2468.
13. Armulik A, Genove´ G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, et al. 2010. Pericytes regulate the blood–brain barrier. Nature 468: 557–561.
14. Armulik A, Genové G, Betsholtz C. 2011. Pericytes: Developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21: 193–215.
15. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. 2010. Glial and neuronal control of brain blood flow. Nature 468: 232–243.
16. Balda MS, Whitney JA, Flores C, González S, Cereijido M, Matter K. 1996. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 134: 1031–1049.
17. Betz AL, Goldstein GW. 1978. Polarity of the blood–brain barrier: Neutral amino acid transport into isolated brain capillaries. Science 202: 225–227.
18. Betz AL, Firth JA, Goldstein GW. 1980. Polarity of the blood–brain barrier: Distribution of enzymes between the luminal and antiluminal membranes of brain capillary endothelial cells. Brain Res 192: 17–28.
19. Biernacki K, Prat A, Blain M, Antel JP. 2001. Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells. J Neuropathol Exp Neurol 60: 1127–1136.
20. Brightman MW, Reese TS. 1969. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol 40: 648–677.
21. Cayrol R, Wosik K, Berard JL, Dodelet-Devillers A, Ifergan I, Kebir H, Haqqani AS, Kreymborg K, Krug S, Moumdjian R, et al. 2008. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol 9: 137–145.
22. Chen XL, Dodd G, Thomas S, Zhang X, Wasserman MA, Rovin BH, Kunsch C. 2006. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol 290: H1862–H1870.
23. Chen J, Stahl A, Krah NM, Seaward MR, Dennison RJ, Sa-pieha P, Hua J, Hatton CJ, Juan AM, Aderman CM, et al. 2011. Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation 124: 1871–1881.
24. Colegio OR, Van Itallie C, Rahner C, Anderson JM. 2003. Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol 284: C1346–C1354.
25. Collard CD, Park KA, Montalto MC, Alapati S, Buras JA, Stahl GL, Colgan SP. 2002. Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem 277: 14801–14811.
26. Conway EM, Carmeliet P. 2004. The diversity of endothelial cells: A challenge for therapeutic angiogenesis. Genome Biol 5: 207.
27. Coomber BL, Stewart PA. 1985. Morphometric analysis of CNS microvascular endothelium. Microvasc Res 30: 99–115.
28. Cordon-Cardo C, O’Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. 1989. Multidrug-resistance gene (P-glycoprotein) is expressed byendothe-lial cells at blood–brain barrier sites. Proc Natl Acad Sci 86: 695–698.
29. Cornford EM, Hyman S, Swartz BE. 1994. The human brain GLUT1 glucose transporter: Ultrastructural localization to the blood–brain barrier endothelia. J Cereb Blood Flow Metab 14: 106–112.
30. Courtoy PJ, Boyles J. 1983. Fibronectin in the microvascu-lature: Localization in the pericyte-endothelial intersti-tium. J Ultrastruct Res 83: 258–273.
31. Cuevas P, Gutierrez-Diaz JA, Reimers D, Dujovny M, Diaz FG, Ausman JI. 1984. Pericyte endothelial gap junctions in human cerebral capillaries. Anat Embryol (Berl) 170: 155–159.
32. Daneman R. 2012. The blood–brain barrier in health and disease. Ann Neurol 72: 648–672.
33. Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, Barres BA. 2009. Wnt/b-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci 106: 641–646.
34. Daneman R, Zhou L, Agalliu D, Cahoy JD, Kaushal A, Barres BA. 2010a. The mouse blood–brain barrier transcriptome: A new resource for understanding the development and function of brain endothelial cells. PLoS ONE 5: e13741.
35. Daneman R, Zhou L, Kebede AA, Barres BA. 2010b. Peri-cytes are required for blood–brain barrier integrity during embryogenesis. Nature 468: 562–566.
36. Del Zoppo GJ, Milner R, Mabuchi T, Hung S, Wang X, Koziol JA. 2006. Vascular matrix adhesion and the blood–brain barrier. Biochem Soc Trans 34: 1261–1266.
37. De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Beh-mand RA, Harik SI. 1991. Defective glucose transport across the blood–brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325: 703–709.
38. De Vivo DC, Leary L, Wang D. 2002. Glucose transporter 1 deficiency syndrome and other glycolytic defects. J Child Neurol 17: 3S15–3S23; discussion 3S24–3S25.
39. Diaz-Flores L, Gutiérrez R, Madrid JF, Varela H, Valladares F, Acosta E, Martín-Vasallo P, Díaz-Flores L Jr. 2009. Peri-cytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 24: 909–969.
40. Dodelet-Devillers A, Cayrol R, van Horssen J, Haqqani AS, de Vries HE, Engelhardt B, Greenwood J, Prat A. 2009. Functions of lipid raft membrane microdomains at the blood–brain barrier. J Mol Med (Berl) 87: 765–774.
41. Dohgu S, Yamauchi A, Takata F, Naito M, Tsuruo T, Higuchi S, Sawada Y, Kataoka Y. 2004. Transforming growth factor-b1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells. Cell Mol Neuro-biol 24: 491–497.
42. Enerson BE, Drewes LR. 2006. The rat blood–brain barrier transcriptome. J Cereb Blood Flow Metab 26: 959–973.
43. Engelhardt B. 2008. Immune cell entry into the central nervous system: Involvement of adhesion molecules and chemokines. J Neurol Sci 274: 23–26.
44. Engelhardt B, Sorokin L. 2009. The blood–brain and the blood–cerebrospinal fluid barriers: Function and dysfunction. Semin Immunopathol 31: 497–511.
45. Fan X, Staitieh BS, Jensen JS, Mould KJ, Greenberg JA, Joshi PC, Koval M, Guidot DM. 2013. Activating the Nrf2-mediated antioxidant response element restores barrier function in the alveolar epithelium of HIV-1 transgenic rats. Am J Physiol Lung Cell Mol Physiol 305: L267–L277.
46. Fischer S, Wobben M, Marti HH, Renz D, Schaper W. 2002. Hypoxia-induced hyperpermeability in brain microves-sel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 63: 70–80.
47. Fischer S, Wiesnet M, Marti HH, Renz D, Schaper W. 2004. Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived en-dothelial cells. J Cell Physiol 198: 359–369.
48. Fontijn RD, Volger OL, Fledderus JO, Reijerkerk A, de Vries HE, Horrevoets AJ. 2008. SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function. Am J Physiol Heart Circ Physiol 294: H891–H900.
49. Furuse M. 2010. Molecular basis of the core structure of tight junctions. Cold Spring Harb Perspect Biol 2: a002907.
50. Furuse M, Sasaki H, Fujimoto K, Tsukita S. 1998. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 143: 391–401.
51. Furuse M, Furuse K, Sasaki H, Tsukita S. 2001. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153: 263–272.
52. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, Noda T, Kubo A, Tsukita S. 2002. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: A lesson from claudin-1-deficient mice. J Cell Biol 156: 1099–111.
53. Gerhardt H, Wolburg H, Redies C. 2000. N-cadherin mediates pericytic–endothelial interaction during brain angiogenesis in the chicken. Dev Dyn 218: 472–479.
54. Ghandour MS, Langley OK, Zhu XL, Waheed A, Sly WS. 1992. Carbonic anhydrase IVon brain capillary endothe-lial cells: A marker associated with the blood–brain barrier. Proc Natl Acad Sci 89: 6823–6827.
55. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, et al. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841–845.
56. Gordon GR, Howarth C, MacVicar BA. 2011. Bidirectional control of arteriole diameter by astrocytes. Exp Physiol 96: 393–399.
57. Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie SE, Danias J, Bronstein JM, Kachar B, Lazzarini RA. 1999. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 99: 649–659.
58. Greenwood J, Heasman SJ, Alvarez JI, Prat A, Lyck R, En-gelhardt B. 2011. Review: Leucocyte-endothelial cell crosstalk at the blood–brain barrier: A prerequisite for successful immune cell entry to the brain. Neuropathol Appl Neurobiol 37: 24–39.
59. Gu Y, Zheng G, Xu M, Li Y, Chen X, Zhu W, Tong Y, Chung SK, Liu KJ, Shen J. 2012. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood–brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem 120: 147–156.
60. Gupta IR, Ryan AK. 2010. Claudins: Unlocking the code to tight junction function during embryogenesis and in disease. Clin Genet 77: 314–325.
61. Ha SN, Hochman J, Sheridan RP. 2007. Mini review on molecular modeling of P-glycoprotein (Pgp). Curr Top Med Chem 7: 1525–1529.
62. Hadj-Rabia S, Baala L, Vabres P, Hamel-Teillac D, Jacquemin E, Fabre M, Lyonnet S, De Prost Y, Munnich A, Had-chouel M, et al. 2004. Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: A tight junction disease. Gastroenterology 127: 1386–1390.
63. Halilagic A, Ribes V, Ghyselinck NB, Zile MH, Dollé P, Studer M. 2007. Retinoids control anterior and dorsal properties in the developing forebrain. Dev Biol 303: 362–375.
64. Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, O’Farrell FM, Buchan AM, Lauritzen M, Attwell D. 2014. Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508: 55–60.
65. Hampson G, Konrad MA, Scoble J. 2008. Familial hypo-magnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): Compound heterozygous mutation in the claudin 16 (CLDN16) gene. BMC Nephrol 9: 12.
66. Henninger DD, Panés J, Eppihimer M, Russell J, Gerritsen M, Anderson DC, Granger DN. 1997. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 158: 1825–1832.
67. Hickey WF, Kimura H. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239: 290–292.
68. Hong JY, Park JI, Cho K, Gu D, Ji H, Artandi SE, McCrea PD. 2010. Shared molecular mechanisms regulate multiple catenin proteins: Canonical Wnt signals and components modulate p120–catenin isoform-1 and additional p120 subfamily members. J Cell Sci 123: 4351–4365.
69. Hou J, Gomes AS, Paul DL, Goodenough DA. 2006. Study of claudin function by RNA interference. J Biol Chem 281: 36117–36123.
70. Huang ZG, Xue D, Preston E, Karbalai H, Buchan AM. 1999. Biphasic opening of the blood–brain barrier following transient focal ischemia: Effects of hypothermia. Can J Neurol Sci 26: 298–304.
71. Huang J, Upadhyay UM, Tamargo RJ. 2006. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66: 232–245.
72. Hudson LC, Bragg DC, Tompkins MB, Meeker RB. 2005. Astrocytes and microglia differentially regulate trafficking of lymphocyte subsets across brain endothelial cells. Brain Res 1058: 148–160.
73. Janzer RC, Raff MC. 1987. Astrocytes induce blood–brain barrier properties in endothelial cells. Nature 325: 253–257.
74. Johnson-Leger CA, Aurrand-Lions M, Beltraminelli N, Fasel N, Imhof BA. 2002. Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration. Blood 100: 2479–2486.
75. Katsimpardi L, Litterman NK, Schein PA, Miller CM, Lof-fredo FS, Wojtkiewicz GR, Chen JW, Lee RT, Wagers AJ, Rubin LL. 2014. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science 344: 630–634.
76. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A. 2007. Human TH17 lymphocytes promote blood–brain barrier disruption and central nervous system inflammation. Nat Med 13: 1173–1175.
77. Keuschnigg J, Henttinen T, Auvinen K, Karikoski M, Salmi M, Jalkanen S. 2009. The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. Blood 114: 478–484.
78. Knohl SJ, Scheinman SJ. 2004. Inherited hypercalciuric syndromes: Dent’s disease (CLC-5) and familial hypomag-nesemia with hypercalciuria (paracellin-1). Semin Neph-rol 24: 55–60.
79. Knowland D, Arac A, Sekiguchi KJ, Hsu M, Lutz SE, Perrino J, Steinberg GK, Barres BA, Nimmerjahn A, Agalliu D. 2014. Stepwise recruitment of transcellular and paracellular pathways underlies blood–brain barrier breakdown in stroke. Neuron 82: 603–617.
80. Krizbai IA, Deli MA, Pestenácz A, Siklós L, Szabó CA, And-rás I, Joó F. 1998. Expression of glutamate receptors on cultured cerebral endothelial cells. J Neurosci Res 54: 814–819.
81. Kuroiwa T, Ting P, Martinez H, Klatzo I. 1985. The biphasic opening of the blood–brain barrier to proteins following temporary middle cerebral artery occlusion. Acta Neuro-pathol 68: 122–129.
82. Larochelle C, Alvarez JI, Prat A. 2011. How do immune cells overcome the blood–brain barrier in multiple sclerosis? FEBS Lett 585: 3770–3780.
83. Larsen JM, Martin DR, Byrne ME. 2014. Recent advances in delivery through the blood–brain barrier. Curr Top Med Chem 14: 1148–1160.
84. Larson DM, Carson MP, Haudenschild CC. 1987. Junctional transfer of small molecules in cultured bovine brain microvascular endothelial cells and pericytes. Microvasc Res 34: 184–199.
85. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML. 2007. Autocrine VEGF signaling is required for vascular homeostasis. Cell 130: 691–703.
86. Lenglet S, Montecucco F, Mach F, Schaller K, Gasche Y, Copin JC. 2014. Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke. Thromb Haemost 112: 363–378.
87. Li JY, Boado RJ, Pardridge WM. 2001. Blood–brain barrier genomics. J Cereb Blood Flow Metab 21: 61–68.
88. Li JY, Boado RJ, Pardridge WM. 2002. Rat blood–brain barrier genomics: II. J Cereb Blood Flow Metab 22: 1319–1326.
89. Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, Reis M, Felici A, Wolburg H, Fruttiger M, et al. 2008. Wnt/b-catenin signaling controls development of the blood–brain barrier. J Cell Biol 183: 409–417.
90. Liu LB, Xue YX, Liu YH. 2010. Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway. J Neurooncol 99: 187–194.
91. Loscher W, Potschka H. 2005. Blood–brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2: 86–98.
92. Ludwig RJ, Zollner TM, Santoso S, Hardt K, Gille J, Baatz H, Johann PS, Pfeffer J, Radeke HH, Schön MP, et al. 2005. Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation. J Invest Dermatol 125: 969–976.
93. Luo J, Ho P, Steinman L, Wyss-Coray T. 2008. Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease. J Neuroinflammation 5: 6.
94. Majesky MW. 2007. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 27: 1248–1258.
95. Mark KS, Davis TP. 2002. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-re-oxygenation. Am J Physiol Heart Circ Physiol 282: H1485–H1494.
96. Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Ruco L, Villa A, et al. 1998. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 142: 117–127.
97. Masuda S, Oda Y, Sasaki H, Ikenouchi J, Higashi T, Akashi M, Nishi E, Furuse M. 2011. LSR defines cell corners for tricellular tight junction formation in epithelial cells. J Cell Sci 124: 548–555.
98. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, Lynch RD, Schneeberger EE. 1996. Occludin is afunctional component of the tight junction. J Cell Sci 109: 2287–2298.
99. Mittapalli RK, Manda VK, Adkins CE, Geldenhuys WJ, Lockman PR. 2010. Exploiting nutrient transporters at the blood–brain barrier to improve brain distribution of small molecules. Ther Deliv 1: 775–784.
100. Miyamoto T, Morita K, Takemoto D, Takeuchi K, Kitano Y, Miyakawa T, Nakayama K, Okamura Y, Sasaki H, Miyachi Y, et al. 2005. Tight junctions in Schwann cells of peripheral myelinated axons: A lesson from claudin-19-deficient mice. J Cell Biol 169: 527–538.
101. Mizee MR, Wooldrik D, Lakeman KA, van het Hof B, Drexhage JA, Geerts D, Bugiani M, Aronica E, Mebius RE, Prat A, et al. 2013. Retinoic acid induces blood–brain barrier development. J Neurosci 33: 1660–1671.
102. Morita K, Sasaki H, Furuse M, Tsukita S. 1999. Endothelial claudin: Claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 147: 185–194.
103. Murakami M, Nguyen LT, Zhuang ZW, Moodie KL, Carme-liet P, Stan RV, Simons M. 2008. The FGF system has a key role in regulating vascular integrity. J Clin Invest 118: 3355–3366.
104. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S. 2003. Size-selective loosening of the blood–brain barrier in claudin-5-deficient mice. J Cell Biol 161: 653–660.
105. Noell S, Wolburg-Buchholz K, Mack AF, Beedle AM, Satz JS, Campbell KP, Wolburg H, Fallier-Becker P. 2011. Evidence for a role of dystroglycan regulating the membrane architecture of astroglial endfeet. Eur J Neurosci 33: 2179–2186.
106. Nourhaghighi N, Teichert-Kuliszewska K, Davis J, Stewart DJ, Nag S. 2003. Altered expression of angiopoietins during blood–brain barrier breakdown and angiogenesis. Lab Invest 83: 1211–1222.
107. Ohtsuki S, Hirayama M, Ito S, Uchida Y, Tachikawa M, Terasaki T. 2014. Quantitative targeted proteomics for understanding the blood–brain barrier: Towards phar-macoproteomics. Expert Rev Proteomics 11: 303–313.
108. Oldendorf WH, Cornford ME, Brown WJ. 1977. The large apparent work capability of the blood–brain barrier: A study of the mitochondrial content of capillary endothe-lial cells in brain and other tissues of the rat. Ann Neurol 1: 409–417.
109. Orlowski M, Sessa G, Green JP. 1974. γ-Glutamyl transpep-tidase in brain capillaries: Possible site of a blood–brain barrier for amino acids. Science 184: 66–68.
110. Paschaki M, Lin SC, Wong RL, Finnell RH, Dollé P, Niederreither K. 2012. Retinoic acid-dependent signaling pathways and lineage events in the developing mouse spinal cord. PLoS ONE 7: e32447.
111. Peppiatt CM, Howarth C, Mobbs P, Attwell D.2006. Bidirectional control of CNS capillary diameter by pericytes. Nature 443: 700–704.
112. Persidsky Y, Ghorpade A, Rasmussen J, Limoges J, Liu XJ, Stins M, Fiala M, Way D, Kim KS, Witte MH, et al. 1999. Microglial and astrocyte chemokines regulate monocyte migration through the blood–brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol 155: 1599–1611.
113. Polfliet MM, Zwijnenburg PJ, van Furth AM, van der Poll T, Do¨pp EA, Renardel de Lavalette C, van Kesteren-Hen-drikx EM, van Rooijen N, Dijkstra CD, van den Berg TK. 2001. Meningeal and perivascular macrophages of the central nervous system play a protective role during bacterial meningitis. J Immunol 167: 4644–4650.
114. Potschka H, Fedrowitz M, Loscher W. 2001. P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major anti-epileptic drug carbamazepine in the brain. Neuroreport 12: 3557–3560.
115. Prat A, Biernacki K, Wosik K, Antel JP. 2001. Glial cell influence on the human blood–brain barrier. Glia 36: 145–155.
116. Reese TS, Karnovsky MJ. 1967. Fine structural localization of a blood–brain barrier to exogenous peroxidase. J Cell Biol 34: 207–217.
117. Reuss B, Dono R, Unsicker K. 2003. Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood–brain barrier permeability: Evidence from mouse mutants. J Neurosci 23: 6404–6412.
118. Rosenberg GA, Estrada EY, Dencoff JE. 1998. Matrix metal-loproteinases and TIMPs are associated with blood–brain barrier opening after reperfusion in rat brain. Stroke 29: 2189–2195.
119. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S. 2000. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11: 4131–4142.
120. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele HP, et al. 1994. Disruption of the mouse mdrla P.-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs. Cell 77: 491–502.
121. Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P. 1995. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexa-methasone, digoxin, and cyclosporin A. J Clin Invest 96: 1698–1705.
122. Schinkel AH, Wagenaar E, Mol CA, van Deemter L. 1996. P-glycoprotein in the blood–brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 97: 2517–2524.
123. Schoch HJ, Fischer S, Marti HH. 2002. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125: 2549–2557.
124. Sharp CD, Hines I, Houghton J, Warren A, Jackson TH IV, Jawahar A, Nanda A, Elrod JW, Long A, Chi A, et al. 2003. Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am J Physiol Heart Circ Physiol 285: H2592–H2598.
125. Shen F, Walker EJ, Jiang L, Degos V, Li J, Sun B, Heriyanto F, Young WL, Su H. 2011. Coexpression of angiopoietin-1 with VEGF increases the structural integrity of the blood–brain barrier and reduces atrophy volume. J Cereb Blood Flow Metab 31: 2343–2351.
126. Shepro D, Morel NM. 1993. Pericyte physiology. FASEB J 7: 1031–1038.
127. Shue EH, Carson-Walter EB, Liu Y, Winans BN, Ali ZS, Chen J, Walter KA. 2008. Plasmalemmal vesicle associated protein-1 (PV-1) is a marker of blood–brain barrier disruption in rodent models. BMC Neurosci 9: 29.
128. Sims DE. 1986. The pericyte—A review. Tissue Cell 18: 153–174.
129. Sorokin L. 2010. The impact of the extracellular matrix on inflammation. Nat Rev Immunol 10: 712–723.
130. Stenman JM, Rajagopal J, Carroll TJ, Ishibashi M, McMa-hon J, McMahon AP. 2008. Canonical Wnt signaling regulates organ-specific assemblyand differentiation of CNS vasculature. Science 322: 1247–1250.
131. Stewart PA, Wiley MJ. 1981. Developing nervous tissue induces formation of blood–brain barrier characteristics in invading endothelial cells: A study using quail–chick transplantation chimeras. Dev Biol 84: 183–192.
132. Streit WJ, Conde JR, Fendrick SE, Flanary BE, Mariani CL. 2005. Role of microglia in the central nervous system’s immune response. Neurol Res 27: 685–691.
133. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. 1989. Immunohistochemical localization in normal tissues of different epitopes in the multi-drug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem 37: 159–164.
134. Ufnal M, Skrzypecki J. 2014. Blood borne hormones in a cross-talk between peripheral and brain mechanisms regulating blood pressure, the role of circumventricular organs. Neuropeptides 48: 65–73.
135. Unger ER, Sung JH, Manivel JC, Chenggis ML, Blazar BR, Krivit W. 1993. Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: A Y-chromosome specific in situ hybridization study. J Neuropathol Exp Neurol 52: 460–470.
136. Van Itallie CM, Anderson JM. 2006. Claudins and epithelial paracellular transport. Annu Rev Physiol 68: 403–429.
137. Van Itallie CM, Anderson JM. 2013. Claudin interactions in and out of the tight junction. Tissue Barriers 1: e25247.
138. Van Itallie C, Rahner C, Anderson JM. 2001. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 107: 1319–1327.
139. Van Itallie CM, Holmes J, Bridges A, Gookin JL, Coccaro MR, Proctor W, Colegio OR, Anderson JM. 2008. The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J Cell Sci 121: 298–305.
140. Vass K, Hickey WF, Schmidt RE, Lassmann H. 1993. Bone marrow-derived elements in the peripheral nervous system. Animmunohistochemical and ultrastructural investigation in chimeric rats. Lab Invest 69: 275–282.
141. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, et al. 2011. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477: 90–94.
142. Villeda SA, Plambeck KE, Middeldorp J, Castellano JM, Mosher KI, Luo J, Smith LK, Bieri G, Lin K, Berdnik D, et al. 2014. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med 20: 659–663.
143. Wang Y, Imitola J, Rasmussen S, O’Connor KC, Khoury SJ. 2008. Paradoxical dysregulation of the neural stem cell pathway Sonic Hedgehog-Gli1 in autoimmune en-cephalomyelitis and multiple sclerosis. Ann Neurol 64: 417–427.
144. Wang Y, Rattner A, Zhou Y, Williams J, Smallwood PM, Nathans J. 2012. Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity. Cell 151: 1332–1344.
145. Westergaard E, Brightman MW. 1973. Transport of proteins across normal cerebral arterioles.J Comp Neurol 152: 17–44.
146. Williams K, Alvarez X, Lackner AA. 2001. Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 36: 156–164.
147. Witt KA, Mark KS, Sandoval KE, Davis TP. 2008. Reoxy-genation stress on blood–brain barrier paracellular permeability and edema in the rat. Microvasc Res 75: 91–96.
148. Wolburg H, Wolburg-Buchholz K, Fallier-Becker P, Noell S, Mack AF. 2011. Structure and functions of aquaporin-4-based orthogonal arrays of particles. Int Rev Cell Mol Biol 287: 1–41.
149. Wong V, Gumbiner BM. 1997. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 136: 399–409.
150. Wosik K, Cayrol R, Dodelet-Devillers A, Berthelet F, Bernard M, Moumdjian R, Bouthillier A, Reudelhuber TL, Prat A. 2007. Angiotensin II controls occludin function and is required for blood brain barrier maintenance: Relevance to multiple sclerosis. J Neurosci 27: 9032–9042.
151. Wu C, Ivars F, Anderson P, Hallmann R, Vestweber D, Nils-son P, Robenek H, Tryggvason K, Song J, Korpos E, et al. 2009. Endothelial basement membrane laminin a5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med 15: 519–527.
152. Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C, Kelley MW, Jiang L, Tasman W, Zhang K, et al. 2004. Vascular development in the retina and inner ear: Control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116: 883–895.
153. Ye X, Wang Y, Nathans J. 2010. The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease. Trends Mol Med 16: 417–425.
154. Yuan SY. 2002. Protein kinase signaling in the modulation of microvascular permeability. Vascul Pharmacol 39: 213–223.
155. Zhao LN, Yang ZH, Liu YH, Ying HQ, Zhang H, Xue YX. 2011. Vascular endothelial growth factor increases permeability of the blood–tumor barrier via caveolae-me-diated transcellular pathway. J Mol Neurosci 44: 122–129.
156. Zlokovic BV. 2008. The blood–brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178–201.